NovaBay Pharmaceuticals Inc (NBY)

[81vette]

is the toxic debt/dilution finally paid off,macd bullish since jan 19th,momentum crossing up over the bullish line,last 2 weekly candles are bullish ones,i am watching for 100k-300k sell/dump(without destroying pps,100k at bid now) to signal the end of dilution/debt,its still zero borrow(last time was early sept)

[81vette]

20k-30k ask slaps,could be go time

[81vette]

cash 3.47M,debt 3M,debt to equity 43%,book value .78,tutes currently 4%,earnings per share up 77%(this year!!)

[81vette]

ZERO BORROW,not optionable,relative buying vol. up 234Xs,institutions or insiders would be only ones buying this much on no news,the Europe deal news might be qued up, i loaded .17 just in case

[TheFinalCD]

https://finviz.com/quote.ashx?t=NBY&p=d

[Monksdream]

NBY new 52=week low

[Monksdream]

NBY new 52 week low

[Monksdream]

NBY new 52 week low

[subslover]

Ha. So did I. Will find something else tomorrow :)

[Invest-in-America]

NBY: I AGREE!!! I dumped it fast --- what JOKE this stuff is, Capt. Subs!!!

[subslover]

They ain't got jack squat! Just a printing press in the basement! :(

[Invest-in-America]

NBY: I need MY eyes fixed with what these guys got!!!

[Golden Cross]

Nice PM Move💵💲

[subslover]

UP 100% pre-market. Happy happy joy joy!

[subslover]

NovaBay Pharmaceuticals Announces Agreement with BioStem Technologies to Commercialize Amniotic Tissue Allograft as Avenova® Allograft
EMERYVILLE, Calif. & POMPANO BEACH, Fla.--(BUSINESS WIRE)-- NovaBay Pharmaceuticals, Inc. (NYSE American: NBY) and BioStem Technologies, Inc. (OTC: BSEM) announce an agreement under which NovaBay has been granted the right to commercialize BioStem Technologies’ Amniotic Tissue Allograft, which is intended for use as a protective covering during the repair of ocular surfaces.

Amniotic Tissue Allograft provides a protective environment or covering for repair of the cornea and conjunctiva, helping ocular surface to return to a healthier state. NovaBay intends to commercialize the prescription-only product as Avenova Allograft to leverage its Avenova eyecare brand and encourage use with other Avenova products. Medically necessary procedures with the Avenova Allograft will be reimbursed through Medicare.

Placentally derived human amniotic membrane is a potent source of pro-healing growth factors and anti-inflammatory cytokines. Amniotic allografts have successfully been used in regenerative medicine for over a century and dehydrated human amniotic membrane continues to be widely used as an ophthalmic covering. Avenova Allograft is the only optic allograft manufactured using BioStem Technologies’ patented six-step BioREtain® process that preserves the natural integrity of the placental tissue. This new NovaBay-branded product will compete in the global ophthalmology amniotic membrane market estimated at $403.6 million in 2022, and is expected to grow at 9.8% per year between 2023-2030.

“Avenova Allograft is a differentiated, high-quality product making it an ideal extension of our eyecare franchise,” said Justin Hall, CEO and General Counsel of NovaBay. “We look forward to launching Avenova Allograft in the coming weeks and making this valuable solution available for the eyecare professionals who specialize in treating dry eye.”

“Avenova Allograft is an ultra-thin, ultra-light structural tissue allograft composed of the amnion layer of the placental membrane. Our proprietary six-step BioREtain manufacturing process preserves the natural components of the tissue critical to the wound healing process and creates a product that is high-quality, versatile, and is applicable to a wide variety of topical ophthalmic covering applications. It is easy to use, and has no harsh chemicals or cryopreservants,” said Jason Matuszewski, CEO of BioStem Technologies. “Our company has an unwavering commitment to innovation, developing superior processes and delivering high-quality products. We manufacture products that change lives!”

About NovaBay Pharmaceuticals, Inc.:

[Golden Cross]

Nice loading zone here

[stock1ace1]

Keep a eye on this tomorrow cvs commercial tomorrow

[stock1ace1]

Nby .71 whos ready for tomorrow ?

[LowFloatLopes]

LOL that’s actually a really good point

[Carjockey2]

Morning..

Question, the Canadian Open is today. How are they going to see the golf ball...lol

[gail]

who’s fb?

[Carjockey2]

I'll answer you after the NBA game, which, yes, is playing tonight...lol

[LowFloatLopes]

Is that even possible lol

[Carjockey2]

Another great call by FB..

Imagine those who were negative instead of positive with him over the last 2 months..

LMAO

LOOSERS

[LowFloatLopes]

LOL

[Carjockey2]

LMAO

Exactly!!!!

Have a great night..

Another great week again, it looks like!!!

[Triple nickle]

Charlie Brown and the little red haired girl

[gail]

[Carjockey2]

This is starting to get ridiculous. You and I are the only ones who are posting on a stock and having it go green...

Lol

Have a great night buddy!!!

[Carjockey2]

Lol..

Weeeeee

[LowFloatLopes]

Nothing at all go away shhhh lol

[Carjockey2]

What's up here..,?

$NBY

[Carjockey2]

Hummm..

NBY

[corvatsch]

there's definitely something coming...
a nice dilution... what a shitty title !!!

[81vette]

10Xs ave volume onna fri,something coming soon?

[81vette]

10Xs ave volume onna fri,something coming soon?

[81vette]

1.5M float,2m o/s,ZERO BORROW soon,only (5k)now,short 160k,analyst target 13.50,book pps $4.00,cash 2.38,gross margin 54%,institution buys up 61%

[81vette]

Loaded the boat

[corvatsch]

PhaseOne Health announced it has provided PhaseOne® Skin and Wound Cleanser as part of a $3 million donation of medical supplies to Ukraine in partnership with the nonprofit Helping Ukraine. For more: https://t.co/UYlTBeUHLe $NBY pic.twitter.com/Kp4lgI5iwU

— NovaBay Pharma (@NovaBayPharma) May 5, 2023

PhaseOne Health announced it has provided PhaseOne® Skin and Wound Cleanser as part of a $3 million donation of medical supplies to Ukraine in partnership with the nonprofit Helping Ukraine.


https://investors.novabay.com/phaseone-health-collaborates-with-nonprofit-humanitarian-organization-to-supply-novabay-pharmaceuticals-phase-one-skin-and-wound-cleanser-to-ukraine/

[corvatsch]

NovaBay Pharmaceuticals Launches DERMAdoctor's New Comfort + Joy Psoriasis Therapeutic Moisturizing Cream on the QVC® Network

https://flashalert.me/?symbol=NBY&source=PR&referer=https://stocktwits.com/&url=http://www.businesswire.com/news/home/20230421005008/en/NovaBay-Pharmaceuticals-Launches-DERMAdoctor%E2%80%99s-New-Comfort-Joy-Psoriasis-Therapeutic-Moisturizing-Cream-on-the-QVC%C2%AE-Network/?feedref=JjAwJuNHiystnCoBq_hl-bV7DTIYheT0D-1vT4_bKFzt_EW40VMdK6eG-WLfRGUE1fJraLPL1g6AeUGJlCTYs7Oafol48Kkc8KJgZoTHgMu0w8LYSbRdYOj2VdwnuKwa&s3=NBY/2023-04-21/06-53-10_000000/bw/215d1f2cb4937a46a0bf70707164712c/NovaBay-Pharmaceuticals-Launches-DERMAdoctor_E2_80_99s-New-Comfort-Joy-Psoriasis-Therapeutic-Moisturizing-Cream-on-the-QVC_C2_AE-Network.html

https://quantisnow.com/insight/4364833

[MasterBlastr]

I don't blame you. That stock has had a history of being flashmobbed without notice.

[Mr. Zen]

looks worthwhile, no news for months though, and I do not have a group.. I will pass.

[MasterBlastr]

If you want a low floater, try QPRC - 4.5 million float, last trade 0.155 . . . get a group on it, pop it to $2 falling out of bed.

[Mr. Zen]

Ordinarily a 2 million share float stock moves on the wind, so not this time... you enjoy laughing at people do you?

[MasterBlastr]

Oh you are in for a quick in/out, pop the float? Nyuk-nyuk?

[Mr. Zen]

What am I missing???

As of November 10, 2022, there were 64,988,364 shares of the registrant's common stock outstanding.

  R/S brings it to 1,857,142 shares in the float.

[MasterBlastr]

Well, that didn't work. This thing has been on a stink run for the longest time . . .

[Mr. Zen]

Grabbed this one (pre-market) for a quick trade on news.

[MasterBlastr]

35 to 1 reverse split.

[Skwerel]

Dumpster fire